Oppenheimer Asset Management Inc. Glaukos Corp Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 14,680 shares of GKOS stock, worth $2.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,680

Previous 18,654 21.3%

Holding current value

$2.24 Million

Previous $2.21 Million 13.37%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$113.62 - $135.39 $451,525 - $538,039	-3,974 Reduced 21.3%	14,680 $1.91 Million
Q2 2024 Aug 08, 2024	BUY	$89.48 - $118.35 $177,349 - $234,569	1,982 Added 11.89%	18,654 $2.21 Million
Q1 2024 May 06, 2024	SELL	$76.4 - $96.33 $407,899 - $514,305	-5,339 Reduced 24.26%	16,672 $1.57 Million
Q4 2023 Feb 13, 2024	SELL	$59.53 - $85.11 $143,586 - $205,285	-2,412 Reduced 9.88%	22,011 $1.75 Million
Q3 2023 Nov 07, 2023	SELL	$69.23 - $79.09 $60,437 - $69,045	-873 Reduced 3.45%	24,423 $1.84 Million
Q2 2023 Aug 02, 2023	BUY	$45.44 - $71.21 $78,929 - $123,691	1,737 Added 7.37%	25,296 $1.8 Million
Q1 2023 May 10, 2023	BUY	$43.88 - $52.48 $126,813 - $151,667	2,890 Added 13.98%	23,559 $1.18 Million
Q4 2022 Feb 06, 2023	SELL	$40.82 - $57.75 $13,837 - $19,577	-339 Reduced 1.61%	20,669 $902,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $242,584 - $302,919	5,179 Added 32.72%	21,008 $1.12 Million
Q2 2022 Aug 08, 2022	SELL	$34.86 - $63.77 $124,833 - $228,360	-3,581 Reduced 18.45%	15,829 $719,000
Q1 2022 May 12, 2022	BUY	$44.33 - $57.82 $253,877 - $331,135	5,727 Added 41.85%	19,410 $1.12 Million
Q4 2021 Feb 02, 2022	BUY	$40.27 - $56.99 $92,741 - $131,247	2,303 Added 20.24%	13,683 $609,000
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $139,017 - $246,878	-2,931 Reduced 20.48%	11,380 $548,000
Q2 2021 Aug 03, 2021	BUY	$73.06 - $97.7 $330,450 - $441,897	4,523 Added 46.21%	14,311 $1.21 Million
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $221,220 - $305,996	3,141 Added 47.25%	9,788 $822,000
Q4 2020 Feb 11, 2021	SELL	$48.9 - $75.26 $306,162 - $471,202	-6,261 Reduced 48.5%	6,647 $500,000
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $133,581 - $182,880	-3,588 Reduced 21.75%	12,908 $639,000
Q2 2020 Aug 11, 2020	BUY	$28.78 - $46.83 $86,800 - $141,239	3,016 Added 22.37%	16,496 $634,000
Q1 2020 May 08, 2020	BUY	$25.53 - $70.14 $96,197 - $264,287	3,768 Added 38.8%	13,480 $416,000
Q4 2019 Feb 07, 2020	SELL	$54.18 - $65.64 $18,367 - $22,251	-339 Reduced 3.37%	9,712 $529,000
Q3 2019 Oct 31, 2019	BUY	$58.58 - $83.91 $335,311 - $480,300	5,724 Added 132.29%	10,051 $628,000
Q2 2019 Aug 09, 2019	BUY	$63.59 - $78.71 $151,916 - $188,038	2,389 Added 123.27%	4,327 $326,000
Q1 2019 Apr 24, 2019	BUY	$50.75 - $80.54 $70,390 - $111,708	1,387 Added 251.72%	1,938 $152,000
Q4 2018 Jan 30, 2019	BUY	$52.18 - $67.93 $28,751 - $37,429	551 New	551 $31,000

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.27B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Glaukos Corp Transaction History